International Ophthalmology

, Volume 32, Issue 6, pp 559–564 | Cite as

Optic disc topographic analysis in diabetic patients

Original Paper


The aim of our study was to evaluate the optic disc (OD) topographic parameters by using Heidelberg Retina Tomograph II (HRT II) in patients with type 2 diabetes mellitus (DM). The study group consisted of 78 patients with type 2 DM (patient group) and age-sex matched 50 healthy subjects (control group). All patients and controls underwent a detailed ophthalmological examination, automated perimetry, central corneal thickness (CCT) measurement and OD topography by using HRT II. Glycosylated haemoglobin (HbA1c) levels of the diabetic patients were also noted. Age, gender, intraocular pressure and CCT measurements were similar in patients with diabetes and control group. Mean retinal nerve fiber layer thickness (MRNFLT) and retinal nerve fiber layer cross-sectional area (RNFLcsA) parameters were found significantly lower in diabetic patients compared to those of the controls (p = 0.030, p = 0.038). In the patient group, MRNFLT value was found significantly lower in patients with DM duration ≥120 months (p = 0.020) and HbA1c level ≥7 % (p = 0.029). Rim volume, MRNFLT and RNFLcsA values were significantly lower in proliferative diabetic retinopathy group (p = 0.004, p = 0.003, p = 0.001 respectively) and laser treated patients (p = 0.003, p = 0.002, p = 0.004 respectively). In conclusion, poor metabolic control of diabetes, severe DR and received laser therapies cause RNFL damage. Heidelberg Retina Tomograph may help us to detect and follow-up the changes in optic disc and RNFL in diabetic patients.


Diabetes mellitus Heidelberg Retina Tomograph Retinal nerve fiber layer thickness Optic disc topography Glycosylated haemoglobin 



This study was presented orally at 44th National Congress of Turkish Ophthalmology Society (29th September–3rd October 2010 Antalya-TURKEY).


  1. 1.
    Ciulla TA, Amador AG, Zinman B (2003) Diabetic retinopathy and diabetic macular edema: pathophysiology, screening and novel therapies. Diabetes Care 26:2653–2664PubMedCrossRefGoogle Scholar
  2. 2.
    Adler AI, Stratton IM, Neil HA, Yudkin JS, Matthews DR, Cull CA, Wright AD, Turner RC, Holman RR (2000) Association of systolic blood pressure with macrovascular and microvascular complications of type 2 diabetes (UKPDS 36): prospective observational study. BMJ 321:412–419PubMedCrossRefGoogle Scholar
  3. 3.
    Königsreuther KA, Jonas JB (1995) Optic disc morphology in diabetes mellitus. Graefes Arch Clin Exp Ophthalmol 233:200–204PubMedCrossRefGoogle Scholar
  4. 4.
    Kurtenbach A, Flogel W, Erb C (2002) Anomaloscope matches in patients with diabetes mellitus. Graefes Arch Clin Exp Ophthalmol 240:79–84PubMedCrossRefGoogle Scholar
  5. 5.
    Zangwill LM, Weinreb RN, Berry CC, Smith AR, Dirkes KA, Liebmann JM, Brandt JD, Trick G, Cioffi GA, Coleman AL, Piltz-Seymour JR, Gordon MO, Kass MA (2004) The confocal scanning laser ophthalmoscopy ancillary study to the ocular hypertension treatment study: study design and baseline factors. Am J Ophthalmol 137:219–227PubMedCrossRefGoogle Scholar
  6. 6.
    Barber AJ, Lieth E, Khin SA, Antonetti DA, Buchanan AG, Gardner TW (1998) Neural apoptosis in the retina during experimental and human diabetes: early onset and effect of insulin. J Clin Invest 102:783–791PubMedCrossRefGoogle Scholar
  7. 7.
    Zhang L, Inoue M, Dong K, Yamamoto Y (2000) Retrograde axonal transport of large and medium-sized retinal ganglion cells in diabetic rat. Curr Eye Res 20:131–136PubMedCrossRefGoogle Scholar
  8. 8.
    Abu El-Asrar AM, Dralands L, Missotten L, Al-Jadaan IA, Geboes K (2004) Expression of apoptosis markers in the retinas of human subjects with diabetes. Invest Ophthalmol Vis Sci 45:2760–2766PubMedCrossRefGoogle Scholar
  9. 9.
    Amano S, Kaji Y, Oshika T, Oka T, Machinami R, Nagai R, Horiuchi S (2001) Advanced glycation end products in human optic nerve head. Br J Ophthalmol 85:52–55PubMedCrossRefGoogle Scholar
  10. 10.
    Van Dijk HW, Verbraak FD, Kok PH, Stehouwer M, Garvin MK, Sonka M, Devries JH, Schlingemann RO, Abramoff MD (2012) Early neurodegeneration in the retina of type 2 diabetic patients. Invest Ophthalmol Vis Sci [Epub ahead of print]Google Scholar
  11. 11.
    Chihara E, Matsuoka T, Ogura Y, Matsumura M (1993) Retinal nerve fiber layer defect as an early manifestation of diabetic retinopathy. Ophthalmology 100:1147–1151PubMedGoogle Scholar
  12. 12.
    Chihara E, Zhang S (1998) Analysis of diabetic optic neuropathy with a topographic laser scanning system. Nippon Ganka Gakkas Zasshi 102:431–435Google Scholar
  13. 13.
    Oshitari T, Hanawa K, Adachi-Usami E (2009) Changes of macular and RNFL thicknesses measured by Stratus OCT in patients with early stage diabetes. Eye 23:884–889PubMedCrossRefGoogle Scholar
  14. 14.
    Lopes de Faria JM, Russ H, Costa VP (2002) Retinal nerve fibre layer loss in patients with type I diabetes mellitus without retinopathy. Br J Ophthalmol 86:725–728PubMedCrossRefGoogle Scholar
  15. 15.
    Sugimoto M, Sasoh M, Ido M, Wakitani Y, Takahashi C, Uji Y (2005) Detection of early diabetic change with optical coherence tomography in type 2 diabetes mellitus patients without retinopathy. Ophthalmologica 219:379–385PubMedCrossRefGoogle Scholar
  16. 16.
    Takahashi H, Chihara E (2008) Impact of diabetic retinopathy on quantitative retinal nerve fiber layer measurement and glaucoma screening. Invest Ophthalmol Vis Sci 49:687–692PubMedCrossRefGoogle Scholar
  17. 17.
    Ozdek S, Lonneville YH, Onol M, Yetkin I, Hasanreisoğlu BB (2002) Assessment of nerve fiber layer in diabetic patients with scanning laser polarimetry. Eye 16:761–765PubMedCrossRefGoogle Scholar
  18. 18.
    Parravano M, Oddone F, Mineo D, Centofanti M, Borboni P, Lauro R, Tanga L, Manni G (2008) The role of Humphrey Matrix testing in the early diagnosis of retinopathy in type 1 diabetes. Br J Ophthalmol 92:1656–1660PubMedCrossRefGoogle Scholar
  19. 19.
    Kim HY, Cho HK (2009) Peripapillary retinal nerve fiber layer thickness change after panretinal photocoagulation in patients with diabetic retinopathy. Korean J Ophthalmol 23:23–26PubMedCrossRefGoogle Scholar
  20. 20.
    Sugimoto M, Sasoh M, Ido M, Narushima C, Uji Y (2010) Retinal nerve fiber layer decrease during glycemic control in type 2 diabetes. J Ophthalmol. doi: 10.1155/2010/569215
  21. 21.
    Tekeli O, Turaçli ME, Atmaca LS, Elhan AH (2008) Evaluation of the optic nerve head with the Heidelberg Retina Tomograph in diabetes mellitus. Ophthalmologica 222:168–172PubMedCrossRefGoogle Scholar
  22. 22.
    Verma A, Raman R, Vaitheeswaran K, Pal SS, Laxmi G, Gupta M, Shekar SC, Sharma T (2011) Does neuronal damage precede vascular damage in subjects with type 2 diabetes mellitus and having no clinical diabetic retinopathy? Ophthalmic Res 47:202–207PubMedCrossRefGoogle Scholar
  23. 23.
    Lim MC, Tanimoto SA, Furlani BA, Lum B, Pinto LM, Eliason D, Prata TS, Brandt JD, Morse LS, Park SS, Melo LA Jr (2009) Effect of diabetic retinopathy and panretinal photocoagulation on retinal nerve fiber layer and optic nerve appearance. Arch Ophthalmol 127:857–862PubMedCrossRefGoogle Scholar
  24. 24.
    Cankaya AB, Ozdamar Y, Ozalp S, Ozkan SS (2011) Impact of panretinal photocoagulation on optic nerve head parameters. Ophthalmologica 225:193–199PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media B.V. 2012

Authors and Affiliations

  1. 1.Department of Ophthalmology, Faculty of MedicinePamukkale UniversityDenizliTurkey

Personalised recommendations